Justin Adam Smith insider trades
Open-market stock purchases and sales by Justin Adam Smith, Director at Journey Medical Corp, from SEC Form 4 filings since Jan 14, 2022.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +59%.
Companies traded
- DERM Journey Medical Corp: 2 buys, last Jul 1, 2026